Caroline Main

The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.

M. Pitt, K. Stein, C. Main, 2010, Health technology assessment.